Surgical site infection and antimicrobial prophylaxis

Published on 02/03/2015 by admin

Filed under Basic Science

Last modified 02/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3541 times

39 Surgical site infection and antimicrobial prophylaxis

Surgery is the branch of medical science that treats injury or disease or improves bodily function through operative procedures. Surgery has been used for thousands of years but has always been complicated to some extent by infection. Currently, surgery is an integral part of the management of many medical conditions and remains the definitive treatment for many cancers. Infections developing at the site of invasive surgical procedures are frequently referred to as surgical site infections. Surgical site infections occur when pathogenic micro-organisms contaminate a surgical wound, multiply and cause tissue damage. The term ‘surgical site infection’ encompasses not only infection at the site of incision but also infections of implants, prosthetic devices and adjacent tissues involved in the operation.

Epidemiology

In England, there are over nine million operations and interventions undertaken each year. Over 50% of these are performed as day cases and many patients are admitted on the day of surgery (Health and Social Care Information Centre, 2009). Healthcare-associated infections (HCAIs), including surgical site infections, complicate around 7% of all hospital admissions (HIS/ICNA, 2007). Surgical site infections are of major clinical importance because they account for 14–16% of all healthcare-associated infections (HPS, 2009; Public Accounts Committee, 2009) and are associated with considerable morbidity and mortality. One-third of peri-operative deaths are related to surgical site infections (Astagneau et al., 2001). It has been estimated that surgical site infections double the length of hospital stay (Coello et al., 2005). While surgical site infections can be common in some procedures, the incidence can be minimised by the care provided before and after the operation, together with the skill of the surgeon (HPS, 2009).

Surveillance

Monitoring the incidence of surgical site infections is hampered by the lack of agreed measuring systems. In particular, to monitor the rates of surgical site infection within an organisation, or to benchmark between organisations, there needs to be a standard approach to diagnosis. Criteria for such a definition have been developed by the Centres for Disease Control and Prevention (CDC) (Mangram et al., 1999) and these are presented in Table 39.1. More detailed surgical site infection scoring systems have been developed but these are time consuming to use.

Table 39.1 Criteria for defining surgical site infection (Mangram et al., 1999)

Type Level Signs and symptoms
Superficial incisional Skin and subcutaneous tissue Localised (Celsian) signs such as redness, pain, heat or swelling at the site of the incision or by the presence of pus within 30 days
Deep incisional Fascial and muscle layers Presence of pus or an abscess, fever with tenderness of the wound, or a separation of the edges of the incision exposing the deeper tissues within 30 days (or 1 year if an implant used)
Organ or space infection Any part of the anatomy other than the incision that is opened or manipulated during the surgical procedure, for example, joint or peritoneum Loss of function of a joint, abscess in an organ, localised peritonitis or collection. Ultrasound or CT scans confirm infection. Within 30 days (or 1 year if implant is used)

Mandatory surveillance for surgical site infections in orthopaedic surgery in the UK was introduced in 2003. In addition, Scotland monitors most other common procedures (http://www.hps.scot.nhs.uk) while in Wales caesarian section is also monitored (http://www.wales.nhs.uk). England has a voluntary reporting system for a broader range of operations (http://www.hpa.org.uk). All report their findings annually. Many surgical site infections, for example, those involving prosthetic joints, often develop late (>28 days post-operation), so post-discharge surveillance schemes are essential. Patients need to be aware how a surgical site infection may present after discharge from hospital. Surveillance of surgical site infections and feedback to the surgical team has been shown to reduce rates of infection (Gastmeier et al., 2005).

Risk factors

Surgical site infections can be categorised into three groups: superficial incisional, deep incisional and organ or space (Fig. 39.1) Whether a wound infection occurs after surgery depends on a complex interaction between the following:

image

Fig. 39.1 Schematic representation of the anatomical classification of surgical site infection

(Horan et al., 1992). Reproduced with permission from the University of Chicago Press.

A system to stratify operative wounds by the expected level of bacterial contamination (Table 39.2) was developed to help predict likely infection rates (Mangram et al., 1999). A number of other factors have also been found to affect the incidence of surgical site infection and are discussed below.

Duration of surgery

The longer the operation, the greater is the risk of wound infection. This, in turn, may be influenced by the experience (Fig. 39.2) speed and skill of the surgeon and is additional to the classification of the operation by risk of infection, for example, clean, contaminated, dirty or infected.

Patient related factors

A number of patient related factors are known to influence the likelihood of developing a surgical site infection and include the following:

Table 39.3 American Society of Anesthesiology (ASA) classification of physical status (Mangram et al., 1999)

ASA score Physical status
1 A normal healthy patient
2 A patient with mild systemic disease
3 A patient with a severe systemic disease that limits activity but is not incapacitating
4 A patient with an incapacitating systemic disease that is a constant threat to life
5 A moribund patient that is not expected to survive 24 h with or without operation

For each surgical procedure, a score of 0–3 is allocated to represent the number of risk factors present. Patients with a score of 0 are at the lowest risk of developing a surgical site infection, while those with a score of 3 have the greatest risk (Table 39.4). Use of this risk index allows comparison of similar patient groups in terms of surgical site infection risk over time. The risk index is a significantly better predictor of surgical-wound risk than the traditional wound classification system and performs well across a broad range of operative procedures.

Table 39.4 Risk index based on presence of co-morbidity and duration of operation (Culver et al., 1991)

Risk index Infection rate (%)
0 1.5
1 2.9
2 6.8
3 13.0

Other factors

There are a number of other risk factors that may increase the risk of a surgical site infection (Table 39.5) for an individual patient but the impact has not been quantified to the extent of those risk factors discussed above.

Table 39.5 Patient and operative risk factors for surgical site infection

Patient risk factors Operative risk factors
Advanced age Tissue ischaemia
Malnutrition Lack of haemostasis
Obesity Tissue damage, for example, crushing by surgical instruments
Concurrent infection Presence of necrotic tissue
Diabetes mellitus Presence of foreign bodies including surgical materials
Liver impairment  
Renal impairment  
Immune deficiency states  
Prolonged preoperative stay  
Blood transfusion  
Smoking  

Smoking

Smoking increases the risk of developing a wound infection (Myles et al., 2002). The mechanism is not known but tobacco use may delay wound healing via the vasoconstricting effects of nicotine and thus increase the risk of infection (Myles et al., 2002).

Pathogenesis

Most surgery involves an incision through one of the body’s protective barriers, typically the skin or other epithelial surface such as the conjunctiva or tympanic membrane. When intact, these provide an excellent barrier to entry of both exogenous and endogenous bacteria into other epithelial surfaces including the mucosal surfaces of the gastro-intestinal and genitourinary tracts, which, when intact, prevent entry of the luminal contents into the surrounding tissues and organs.

Any surgical operation will breach at least one of the surfaces mentioned and allow entry of bacteria. Whether an infection follows depends on the ability of other defences to kill the invading bacteria. Important host mechanisms include antibodies, complement and phagocytes.

Development of a surgical site infection depends on survival of the contaminating micro-organism in a wound site at the end of a surgical procedure; the pathogenicity and number of these micro-organisms; and the host’s immune response. Most micro-organisms are from the host (endogenous), but are occasionally introduced via surgical instruments, the environment or contaminated implants (exogenous). The likely invading micro-organism varies according to the type of surgery (Table 39.6). Data for England from 2003 to 2007 has shown that the predominant organism was Staphylococcus aureus, which accounted for 38% of all surgical site infections (Fig. 39.4); 64% of these were caused by a meticillin-resistant strain (MRSA). The proportion of surgical site infections caused by S. aureus was highest in hip hemiarthroplasty (57%), followed by limb amputation (54%) and open reduction of long bone fracture (52%). Enterobacteriaceae (coliforms) caused the second largest group of infections, accounting for 21% of all surgical site infections. These were the prominent causes of surgical site infections in three categories: large bowel surgery (33%), coronary artery bypass graft (32%) and small bowel surgery (30%).

Table 39.6 Likely pathogens in post-operative wound infections

Category of surgery Most likely pathogen(s)
Clean
Cardiac/vascular/orthopaedic Breast Coagulase-negative staphylococci, S. aureus, Gram-negative bacilliS. aureus
Clean-contaminated
Burns S. aureus, Pseudomonas aeruginosa
Head and neck Gastro-intestinal tract S. aureus, Streptococcus spp., anaerobes (from oral cavity)Coliforms, anaerobes (Bacteroides fragilis)
Urogenital tract Coliforms, Enterococcus spp.
Dirty
Ruptured viscera Coliforms, anaerobes (B. fragilis)
Traumatic wound S. aureusStreptococcus pyogenes, Clostridium spp.

Although there was a significant reduction in the risk of a surgical site infection for all categories over the 5 year period monitored, there was no change in the proportion of S. aureus, infections that were due to MRSA. Infection control measures including the introduction of mandatory MRSA screening for elective patients in 2009 should improve this. Known or previous MRSA carriers can be ‘decolonised’ and appropriate prophylactic antimicrobials administered that cover MRSA (e.g. teicoplanin).